Femasys Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device
Go back to Femasys Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device| (NASDAQ: FEMY) | Delayed: 3.99 +0.14 (3.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.85 | 52 Week High | $ | |||
| Open | $3.88 | 52 Week Low | $ | |||
| Day High | $4.07 | P/E | N/A | |||
| Day Low | $3.88 | EPS | $ | |||
| Volume | 27,172 | |||||

